PARAPHARM DEVELOPMENT LIMITED

09948940
Active Windsor

Wholesale of pharmaceutical goods

0 employees website.com
Healthcare and wellbeing Wholesale of pharmaceutical goods
P

PARAPHARM DEVELOPMENT LIMITED

09948940

Wholesale of pharmaceutical goods

Founded 13 Jan 2016 Active Windsor, England 0 employees website.com
Healthcare and wellbeing Wholesale of pharmaceutical goods
Accounts Submitted 4 Apr 2025 Next due 30 Sept 2026 3 months remaining
Confirmation Submitted 26 Feb 2026 Next due 26 Jan 2027 7 months remaining
Net assets £7M £5M 2024 year on year
Total assets £8M £4M 2024 year on year
Total Liabilities £240K £931K 2024 year on year
Charges None No charges registered

Contact & Details

Contact

Registered Address

St Stephens House Arthur Road Windsor Berkshire SL4 1RU England

Email

info@example.com

Website

www.example.com

Full company profile for PARAPHARM DEVELOPMENT LIMITED (09948940), an active healthcare and wellbeing company based in Windsor, England. Incorporated 13 Jan 2016. Wholesale of pharmaceutical goods. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jan → 31 Dec 2024
Type small
Next accounts 31 Dec 2025
Due by 30 Sept 2026 3 months remaining

Net Assets, Total Assets & Total Liabilities (2016–2024)

Cash in Bank

£190.56k

Decreased by £104.60k (-35%)

Net Assets

£7.36M

Increased by £5.10M (+226%)

Total Liabilities

£239.88k

Decreased by £930.71k (-80%)

Turnover

N/A

Employees

N/A

Debt Ratio

3%

Decreased by 31 (-91%)

Financial History

Revenue, profit, EBITDA and key financial figures

2024
31 Dec Year End
2023
31 Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

No fundraising or grants recorded

Investors (0)

No investor information available

Share Capital

Share Capital

Share allotments and capital structure

1 Allotment 3,049,900 Shares £3.05m Total
Date FromShare ClassShares AllottedAmount RaisedPrice/Share
30 Nov 20183,049,900£3.05m£3.05m

Officers

Officers

2 active 1 resigned
Status
Clark, GrahamSecretaryUnknownUnknown31 Mar 2020Active
Phelps, CharlotteDirectorUnited KingdomEngland6113 Jan 2016Active

Shareholders

Shareholders (1)

Nordic Pharma Limited
100.0%
1,000

Persons with Significant Control

Persons with Significant Control (2)

2 Active

Frederik Dag Arfst Paulsen

Swedish

Active
Notified 21 Nov 2018
Residence Switzerland
DOB October 1950
Nature of Control
  • Significant Influence Or Control

Nordic Pharma Limited

United Kingdom

Active
Notified 12 Jul 2024
Nature of Control
  • Ownership Of Shares 75 To 100 Percent

Group Structure

Group Structure

NORDIC PHARMA LIMITED united kingdom
PARAPHARM DEVELOPMENT LIMITED Current Company
TRANSDERMAL LIMITED united kingdom

Charges

Charges

No charges registered

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
26 Feb 2026Confirmation StatementConfirmation statement made on 12 Jan 2026 with no updates
4 Apr 2025AccountsAnnual accounts made up to 31 Dec 2024
24 Jan 2025Confirmation StatementConfirmation statement made on 12 Jan 2025 with updates
13 Jan 2025CapitalStatement by Directors
13 Jan 2025CapitalCapital Statement Capital Company With Date Currency Figure
26 Feb 2026 Confirmation Statement

Confirmation statement made on 12 Jan 2026 with no updates

4 Apr 2025 Accounts

Annual accounts made up to 31 Dec 2024

24 Jan 2025 Confirmation Statement

Confirmation statement made on 12 Jan 2025 with updates

13 Jan 2025 Capital

Statement by Directors

13 Jan 2025 Capital

Capital Statement Capital Company With Date Currency Figure

Recent Activity

Latest Activity

Confirmation statement made on 12 Jan 2026 with no updates

4 months ago on 26 Feb 2026

Annual accounts made up to 31 Dec 2024

1 years ago on 4 Apr 2025

Confirmation statement made on 12 Jan 2025 with updates

1 years ago on 24 Jan 2025

Statement by Directors

1 years ago on 13 Jan 2025

Capital Statement Capital Company With Date Currency Figure

1 years ago on 13 Jan 2025